Microbe-associated molecular pattern (MAMP)

Microbe-associated molecular patterns (MAMPs), also known as pathogen-associated molecular patterns (PAMPs), are highly conserved molecular structures produced by microorganisms that are absent in host tissues, serving as critical signals for the innate immune system [1][2]. These patterns include a diverse array of chemical structures such as lipopolysaccharide (LPS) from Gram-negative bacteria, peptidoglycan from Gram-positive bacteria, flagellin, and microbial nucleic acids like double-stranded RNA [3]. Recognition of MAMPs is mediated by host germline-encoded pattern recognition receptors (PRRs), which trigger downstream signaling cascades (e.g., NF-κB and IRF pathways) to induce the expression of pro-inflammatory cytokines and type I interferons [1][4]. In clinical practice, MAMPs are of significant importance both as drivers of disease and as therapeutic tools. While the systemic release of MAMPs during infection can lead to life-threatening conditions like sepsis and septic shock through hyper-activation of the immune system, controlled delivery of synthetic MAMP analogs is widely used in vaccine development as adjuvants to boost the adaptive immune response [2][3]. Furthermore, therapeutic strategies targeting MAMPs often focus on neutralization (such as using Polymyxin B to bind LPS) to mitigate the damaging effects of excessive inflammation during severe infections [4]. Sources: [1] Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002;20:197-216. [2] Mogensen TH. Pathogen-recognized regulatory pathways and their role in inflammation. Front Immunol. 2014;5:350. [3] Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30(1):16-34. [4] Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249(1):158-175.

Other names

Pathogen-associated molecular patternPAMPMicrobial patternMicrobe-derived molecular pattern

MAMPs act as exogenous ligands or agonists that bind to host Pattern Recognition Receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to initiate innate immune signaling; therapeutic agents may either mimic MAMPs to act as adjuvants or sequester/neutralize them to prevent excessive inflammatory responses.